Frontiers in endocrinology

Front Endocrinol (Lausanne) · ISSN (print) 1664-2392 · 981 papers in corpus
meta-analysis 2024
doi:10.3389/fendo.2024.1489783 ·PMID:39736864

PURPOSE: Infertility is affecting more and more couples of appropriate age. Hysteroscopy (HSC) has certain effects on the uncompleted pregnancy and live birth caused by uterine microenvironment. Based on the evidence, this paper systematica…

review 2024
doi:10.3389/fendo.2024.1435121 ·PMID:39415794

The increase in female reproductive disorders, such as polycystic ovary syndrome, endometriosis, and diminished ovarian reserve that lead to subfertility and infertility, has encouraged researchers to search and discover their underlying ca…

review 2023
doi:10.3389/fendo.2023.1199569 ·PMID:37455911

Endometriosis is a gynecological condition that significantly impacting women's daily lives. In recent years, the incidence of endometriosis has been rising yearly and is now an essential contributor to female infertility. Exosomes are extr…

observational 2023
doi:10.3389/fendo.2023.1098131 ·PMID:36967754

OBJECTIVE: To explore the cumulative outcomes and influencing factors of patients with discrepancies between age and Anti-Müllerian hormone (AMH) levels in the early follicular phase prolonged protocol. METHODS: A total of 1282 cycles of i…

review 2023
doi:10.3389/fendo.2023.1118168 ·PMID:37223034

Placenta accreta spectrum disorder (PAS) is a kind of disease of placentation defined as abnormal trophoblast invasion of part or all of the placenta into the myometrium, even penetrating the uterus. Decidual deficiency, abnormal vascular r…

2023
doi:10.3389/fendo.2023.1074347 ·PMID:36742391

BackgroundReliable predictive models for predicting excessive and poor ovarian response in controlled ovarian stimulation (COS) is currently lacking. The dynamic (Δ) inhibin B, which refers to increment of inhibin B responding to exogenous …

lab-animal 2023
doi:10.3389/fendo.2023.1158527 ·PMID:37293500

INTRODUCTION: Endometriosis is defined as the growth of endometrial glands and stromal cells in a heterotopic location with immune dysregulation. It usually leads to chronic pelvic pain and subfertility. Although various treatments are avai…

review 2023
doi:10.3389/fendo.2023.1273966 ·PMID:38027144

Anti-Müllerian hormone (AMH), an indirect indicator of the number of remaining follicles, is clinically used as a test for ovarian reserve. Typically, a decline suggests a decrease in the number of remaining follicles in relation to ovarian…

observational 2023
doi:10.3389/fendo.2023.1315099 ·PMID:38274228

INTRODUCTION: Female infertility is defined as the absence of clinical pregnancy after 12 months of regular unprotected sexual intercourse. METHODS: This study employed metabolomics and proteomics approaches to investigate the relationship…

observational 2023
doi:10.3389/fendo.2023.1086924 ·PMID:37206442

OBJECTIVES: This study aimed to investigate whether the FSH (follicle-stimulating hormone)/LH (Luteinizing hormone) ratio correlates with ovarian response in a cross-sectional retrospective study of a population with normal levels of anti-M…

other 2023
doi:10.3389/fendo.2023.1223181 ·PMID:37795369

INTRODUCTION: The failure of remodeling the spiral arteries is associated with the pathogenesis of preeclampsia. Estradiol (E2) plays a crucial role in placentation and may be involved in the development of preeclampsia. However, there is a…

meta-analysis 2023
doi:10.3389/fendo.2023.1183219 ·PMID:37424857

BACKGROUND: Recent studies have indicated a potential correlation between intestinal bacteria and primary ovarian insufficiency (POI). However, the causal relationship between the gut microbiota (GM) and POI remains unclear. METHODS: A bid…

observational 2023
doi:10.3389/fendo.2023.1206326 ·PMID:37711897

PURPOSE: Investigate whether local angiotensin II (AngII) and its AngII type 1 and 2 receptors (AT1R, AT2R) in the endometrium are different and correlate with microvessel density in women with reproductive failure and pregnancy outcomes. …

observational 2023
doi:10.3389/fendo.2023.1286391 ·PMID:38260134

BACKGROUND: Phthalates are ubiquitously used in a variety of products and have an adverse effect on folliculogenesis. However, previous epidemiological studies on the associations between phthalate exposure and antral follicle count (AFC) p…

observational 2023
doi:10.3389/fendo.2023.1320893 ·PMID:38327901

INTRODUCTION: Personal care products (PCPs) contain a number of endocrine-disrupting chemicals (EDCs) that could potentially affect the reproductive function in women of childbearing age. However, studies focused on the effects of PCPs use …

rct 2023
doi:10.3389/fendo.2023.1144323 ·PMID:37020589

PURPOSE: In a randomized, triple-blind, placebo-controlled clinical trial (RCT) including 50 infertile women with endometriosis candidate for assisted reproductive techniques (ART), we studied the effect of Astaxanthin (AST) on pro-inflamma…

other 2023
doi:10.3389/fendo.2023.1137235 ·PMID:37008951

Endometriosis has a detrimental effect on oocyte quality, and ovarian endometriosis (OEM) and peritoneal endometriosis (PEM) may have different effects on female fertility. Therefore, we conducted a study to explore the circular RNA (circRN…

other 2023
doi:10.3389/fendo.2023.1131771 ·PMID:36967756

To figure out the differentially changed metabolites and disturbed pathways in follicular fluid (FF) of patients with OHSS in comparison to the control group undergoing in vitro fertilization (IVF), we conducted this metabolomic analysis be…

other 2023
doi:10.3389/fendo.2023.1026168 ·PMID:36967761

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of th…

other 2023
doi:10.3389/fendo.2023.1295412 ·PMID:38027179

PURPOSE: The relationship between dyslipidemia and female reproductive endocrine diseases has been increasingly studied. The use of lipid-lowering drugs in treating various related diseases, including coronary heart disease, may affect fema…

observational 2023
doi:10.3389/fendo.2023.1278531 ·PMID:38027112

BACKGROUND: Lifetime traumatic events are prevalent in women with Premenstrual Dysphoric Disorder (PMDD) and predict stronger premenstrual symptom intensities. Less is known about the unique effects of childhood adversity on PMDD. This stud…

review 2023
doi:10.3389/fendo.2023.1324429 ·PMID:38192421

The ovarian microenvironment is critical for follicular development and oocyte maturation. Maternal conditions, including polycystic ovary syndrome (PCOS), endometriosis, and aging, may compromise the ovarian microenvironment, follicular de…

observational 2023
doi:10.3389/fendo.2022.1034614 ·PMID:36743927

OBJECTIVES: Endometriosis (EM) is an estrogen-dominant inflammatory disease linked to infertility that affects women of reproductive age. EM lesions respond to hormonal signals that regulate uterine tissue growth and trigger inflammation an…

observational 2023
doi:10.3389/fendo.2023.1120115 ·PMID:36742409

BACKGROUND: Puberty marks the transition from childhood to adulthood and is initiated by activation of a pulsatile GnRH secretion from the hypothalamus. MKRN3 functions as a pre-pubertal break on the GnRH pulse generator and hypothalamic ex…

meta-analysis 2023
doi:10.3389/fendo.2023.1215755 ·PMID:38027219

OBJECTIVE: To appraise the current randomized clinical trials (RCTs) for evidence of the association of growth hormone (GH) with improved outcomes in infertile women with diminished ovarian reserve (DOR) undergoing in vitro fertilization (I…